Researchers at Aston University have found that the highly toxic metal gallium can selectively destroy “greedy” cancer cells with an astonishing 99% success rate.¹
By exploiting the appetite of malignant cells for nutrients and minerals, scientists have developed bioactive glasses infused with gallium that target and kill bone cancer cells while leaving healthy tissues unharmed.
This targeted approach eradicates tumors and shows promise in regenerating diseased bones. Could this be the long-awaited breakthrough in the fight against deadly cancers?
Pioneering a New Era in Cancer Treatment
Led by Professor Richard Martin, the research team incubated the gallium-doped bioactive glasses in simulated body fluid.
Within seven days, they observed the early stages of bone formation, demonstrating the material’s potential to eradicate tumors and regenerate diseased bones.
While previous studies have shown technetium-99m and other radioactive elements like indium-111 and thallium-201 can damage DNA and slow tumor growth, gallium’s unique “Trojan horse” strategy sets it apart.
By exploiting cancer cells’ iron metabolism, gallium can infiltrate and destroy tumors with unrivaled specificity.
Overcoming Chemoresistance & Improving Outcomes
One of the greatest challenges in cancer treatment is chemoresistance, which leads to recurrence and, tragically, the deaths of many patients.
Researchers hope to overcome intrinsic and acquired resistance to conventional therapies by harnessing gallium’s targeted toxicity.
Early diagnosis also plays a crucial role in treatment success. Detecting cancer before it has a chance to develop extensive heterogeneity and drug resistance could vastly improve patient outcomes.
Early detection can enhance cancer survival rates with innovative approaches like gallium-based therapies.
The Future of Gallium in Cancer Treatment
The Aston University team’s success builds upon prior research that achieved a 50% reduction in cancer cell survival using gallium. However, this near-total elimination of bone cancer cells marks a significant leap forward.
The scientists are now focusing on securing additional funding to advance their gallium-based treatments into clinical trials.
As research continues to uncover novel methods for destroying cancer cells, from molecular vibration techniques to immunotherapies harnessing natural killer cells, the future of cancer treatment looks increasingly promising.
Gallium’s remarkable ability to precisely target and eliminate bone cancer cells offers new hope for patients facing this devastating disease.
- Gallium maltolate, an orally available form of gallium, has shown promise in treating glioblastoma, a rare and aggressive brain cancer.
- Gallium compounds have been used in nuclear medicine and oncology for imaging and therapy, and their importance in this field is still growing.
- Injectable composite hydrogels embedded with gallium-based liquid metal particles have demonstrated significant tumor suppression through photothermal therapy and chemotherapy.
Source:
Read Next:
Martha A. Lavallie
Martha is a journalist with close to a decade of experience in uncovering and reporting on the most compelling stories of our time. Passionate about staying ahead of the curve, she specializes in shedding light on trending topics and captivating global narratives. Her insightful articles have garnered acclaim, making her a trusted voice in today's dynamic media landscape.
